Skip to main content

Frequently asked questions

What is carcinoid syndrome diarrhea (CSD)?

CSD is the frequent, watery diarrhea that is one of the most common symptoms in patients with functioning neuroendocrine tumors (NETs)/carcinoid syndrome (CS).

What causes CSD?

CSD is caused mainly by too much serotonin. Some NETs produce too much serotonin in the gut, which can lead to frequent, watery diarrhea.

What is XERMELO used for?

XERMELO is a prescription medicine used together with somatostatin analog (SSA) injections to treat CSD in adults whose diarrhea isn't adequately controlled by SSA injections alone. 

Do I stop taking my SSA if I start XERMELO?

No. XERMELO is taken in combination with SSA injections, not in place of it. 

How does XERMELO work?

XERMELO works by reducing the overproduction of serotonin from NET cells, which plays a role in causing CSD.

When should I see results with XERMELO?

Based on the results of a clinical trial, patients can expect to see improvements in 12 weeks and some patients may start to see results within 1 to 3 weeks.

How do I take XERMELO?

XERMELO is an oral medication taken three times a day with food. 

What should I do if I miss a dose?

If you miss a dose of XERMELO, simply take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. 

How is XERMELO packaged?

XERMELO is dispensed in a monthly case containing four weekly packs; each weekly pack contains 21 tablets, for a 28-day supply (84 tablets total). 

Is financial support available for XERMELO?

Yes, XERMELO offers programs to eligible patients to help with cost. See our support programs and learn more about eligibility and how to enroll in these programs.

Access and support

TerSera SupportSource has many resources to help

Get support

Co-pay support

You could pay as little as $0 co-pay
if you have commercial insurance*

See if you’re eligible

Questions about treatment?

Our Clinical Nurse Educators can help answer your questions

Get dedicated support

*For eligible commercially insured patients, the co-⁠pay card is subject to an annual limit. You are not eligible if prescriptions are paid for by any state or other federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA, DOD, TRICARE, or where prohibited by law. Additional terms and conditions apply.

Important Safety Information

  • Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
  • XERMELO may cause constipation which can be serious. You should stop

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Important Safety Information

  • Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening 
abdominal pain develops. Talk to your doctor if you have these symptoms.
  • The most common side effects of XERMELO include nausea, headache, increase in liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, fever, abdominal pain, and constipation.
  • Talk to your doctor about all medications you are taking as some may interact with XERMELO.
  • XERMELO is not recommended if you have moderate or severe liver impairment.

You are encouraged to report negative side effects of prescription drugs to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Please see accompanying Full Prescribing Information.

Important Safety Information and Indication

Important Safety Information

  • Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
  • XERMELO may cause constipation which can be serious. You should stop

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Important Safety Information

  • Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening 
abdominal pain develops. Talk to your doctor if you have these symptoms.
  • The most common side effects of XERMELO include nausea, headache, increase in liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, fever, abdominal pain, and constipation.
  • Talk to your doctor about all medications you are taking as some may interact with XERMELO.
  • XERMELO is not recommended if you have moderate or severe liver impairment.

You are encouraged to report negative side effects of prescription drugs to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Please see accompanying Full Prescribing Information.

Attention

If you click “Continue” below, you will leave the current site. TerSera is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Continue
Cancel

Healthcare Professionals

The information contained in this section of the site is intended for US Healthcare Professionals only. Click Continue if you are a US Healthcare Professional.

Continue
Cancel

Healthcare Professionals

The information contained in this section of the site is intended for US Healthcare Professionals only. Click Continue if you are a US Healthcare Professional.

Cancel

NPI lookup

To find your NPI number, please fill out the information below.

Fields marked with an asterisk (*) are required.

Enter your first name.
Enter your last name.
Select your state.

Search results

Select the entry with your name and address information.  

Name NPI number State ZIP Code  

No results found

Refine your search and try again.